Peijun Zuo

1.4k citations
3 papers · 12 indexed · h-index 2
Topics
Neurological Disease Mechanisms and Treatments (1 paper)Traditional Chinese Medicine Analysis (1 paper)Cancer Immunotherapy and Biomarkers (1 paper)
Partner nations
ChinaIndiaIran

In The Last Decade

Peijun Zuo

3 papers receiving 12 citations

Peers

Peijun Zuo
Comparison fields: 5 of 19
  • Cellular and Molecular Neuroscience 4
  • Physiology 4
  • Pharmacology 3
  • Complementary and alternative medicine 3
  • Biological Psychiatry 2
Replace Mengyue Fang with:
Mengyue Fang China
Julia Fabienne Sandkühler United Kingdom
Ashling Giblin United Kingdom
Joshua J. Dennis Australia
Sreelatha Akkala United States
Kristi Tucker United States
Christopher Sefton United States
Mourad Wahba United Kingdom
L. Zhou China
K. T. Flood United States
Peijun Zuo relative to Mengyue Fang China Mengyue Fang's profile →
Citations per field
00.5×1.5×
Mengyue Fang · 1×
Citations per year

Countries citing papers authored by Peijun Zuo

Since Specialization
Citations

This map shows the geographic impact of Peijun Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peijun Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peijun Zuo more than expected).

Fields of papers citing papers by Peijun Zuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peijun Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peijun Zuo. The network helps show where Peijun Zuo may publish in the future.

Co-authorship network of co-authors of Peijun Zuo

This figure shows the co-authorship network connecting the top 25 collaborators of Peijun Zuo. A scholar is included among the top collaborators of Peijun Zuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peijun Zuo. Peijun Zuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

3 of 3 papers shown
#WorkIndexed citations
1 1
2 9
3
[Protective mechanism of tianmacuzhi granules in brain].
2

About Peijun Zuo

Peijun Zuo is a scholar working on Biological Psychiatry, Complementary and alternative medicine and Neurology, having authored 3 papers that have together received 12 indexed citations. Recurring topics across this work include Neurological Disease Mechanisms and Treatments (1 paper), Traditional Chinese Medicine Analysis (1 paper) and Cancer Immunotherapy and Biomarkers (1 paper). The work is most often cited by research in Biological Psychiatry (2 citations), Complementary and alternative medicine (3 citations) and Toxicology (1 citation). Peijun Zuo has collaborated with scholars based in China, India and Iran. Frequent co-authors include Dileep Kumar, Natália Martins, Liping Li, Shahira M. Ezzat, Sakshi Painuli, Javad Sharifi‐Rad, Yasaman Taheri, Wissam Zam, Prabhakar Semwal and Yongdong Niu. Their work appears in journals such as Frontiers in Immunology, Combinatorial Chemistry & High Throughput Screening and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026